We are thrilled to announce that our 1st anti-adhesion medical device, the SPORONGE Intranasal Splint, has received approval from Singapore’s Health Science Authority (HSA)! This milestone is a testament to our commitment to enhancing patient care and advancing medical technology. The SPORONGE Intranasal Splint is designed to minimize bleeding and edema and prevent adhesions between […]
Intranasal Splint Approval by HSA Read More »
Sporogenics is now a member of co11ab. co11ab is a Singapore biomedtech incubator formed by Nanyang Technological University (NTU), A*STAR and National Health Group (NHG) to nurture and support translational development of biomedical technologies.
Sporogenics is now a member of co11ab Read More »
Sporogenics was featured on the latest issue on an online UK magazine, please click below link to read more about Sporogenics’s story and aspiration. https://ghp-news.com/issues/q1-2021/42/
Sporogenics was featured on the latest issue on an online UK magazine Read More »
Sporogenics is honored to be the recipient of JLabs Award at MedTech Innovator Asia Pacific 2020 Grand Final for 1 year residency at Johnson & Johnson Innovation JLabs@Shanghai: https://www.businesswire.com/news/home/20201117006364/en/MedTech-Innovator-Names-X-ZELL-as-2020-Asia-Pacific-Final-Competition-Winner
Sporogenics is honored to be the recipient of JLabs Award Read More »
Please support us to join the quest to improve surgical outcomes by preventing postsurgical adhesion! https://medtechinnovator.org/medtech-innovator-asia-pacific-finalists-2020/
Sporogenics made it into the Grand Finals! Read More »
Check the website for details: https://www.apacmedvirtualforum.com
https://www.businesswire.com/news/home/20200713005698/en/MedTech-Innovator-Selects-20-Startups-Annual-Asia
Among over 180 submissions, Sporogenics is delighted to be selected as one of the 40 medtech startups for an online pitch session on 26 May 2020 during the global pandemic due to COVID-19. It was a great learning experience interacting with industry experts such as from Johnson and Johnson, Baxter, Oliver Healthcare Packaging etc.
Sporogenics participated in MedTech Innovator APAC 2020 Read More »
Dec 2, 2019 Baxter International said Monday it plans to acquire Sanofi’s surgical products unit Seprafilm and related assets for $350 million in cash, confirming October speculation the Deerfield, Illinois-based healthcare products company and French pharma were weighing a deal. The deal gives Baxter’s surgery division an adhesion barrier product meant to reduce incidence and
Baxter picks up Sanofi’s Seprafilm adhesion barrier for $350M Read More »
